ArticleMedical oncology (Northwood, London, England)2026
Survivin mRNA lipid nanoparticles and CTLA-4 inhibitor co-delivery activates anti-tumor cytotoxic T-lymphocytes for oral cancer immunotherapy.
Vandana Krishna et al.PubMed ↗Publisher ↗
No numbers read from the abstract.